News & Events

CPHI Korea 2027
24-26 Aug 2027

COEX, Grand Intercontinental, Seoul, Korea

BOOTH DC34
Vitafoods Asia 2027
21-23 Sep 2027

MITEC, Kuala Lumpur, Malaysia

BOOTH 8-F19
Vitafoods Europe 2027
18-20 May 2027

Fira Barcelona Gran Via, Barcelona, Spain

BOOTH 2A234
Hi & Fi China 2027
22-24 June 2027

NECC Shanghai, China

BOOTH 21F57
SupplySide Global 2026
28-30 Oct 2025

Mandalay Bay, Las Vegas, USA

BOOTH 6076
CPHI India 2026
23-25 Nov 2025

Yashobhoomi, New Delhi, India

BOOTH 2J15
Vitafoods India 2027
9-11 Feb 2026

JWCC, Mumbai, India

BOOTH C14

Blog

Stay informed with our latest news, research, and industry insights.​

Phaseolean®: Carb control & satiety signalling to target body’s GLP-1, PYY & Ghrelin levels

New clinical studies showcase Phaseolean®'s effects on endogenous GLP-1, PYY and Ghrelin, adding to the established science of α-amylase inhibition, postprandial glycemic control and weight management

Phaseolean®: Carb control & satiety signalling to target body’s GLP-1, PYY & Ghrelin levels

New clinical studies showcase Phaseolean®'s effects on endogenous GLP-1, PYY and Ghrelin, adding to the established science of α-amylase inhibition, postprandial glycemic control and weight management

Celebrating 20 years of nature-inspired innovation: Ambe Phytoextracts

Twenty years ago, Ambe Phytoextracts began its journey with a simple belief in nature’s potential to improve human health. From humble beginnings with conviction, the company evolved into a science-driven organisation with a strong presence in the pristine Himalayan region of Uttarakhand.

Celebrating 20 years of nature-inspired innovation: Ambe Phytoextracts

Twenty years ago, Ambe Phytoextracts began its journey with a simple belief in nature’s potential to improve human health. From humble beginnings with conviction, the company evolved into a science-driven organisation with a strong presence in the pristine Himalayan region of Uttarakhand.

Phaseolean®: Carb control & satiety signalling to target body’s GLP-1, PYY & Ghrelin levels

New clinical studies showcase Phaseolean®'s effects on endogenous GLP-1, PYY and Ghrelin, adding to the established science of α-amylase inhibition, postprandial glycemic control and weight management

Get In Touch